Literature DB >> 25091680

Rotavirus infections in a community based cohort in Vellore, India.

Anu Paul1, Beryl P Gladstone1, Indrani Mukhopadhya1, Gagandeep Kang2.   

Abstract

INTRODUCTION: The burden of infection in communities determines the spread of rotavirus infection and disease in susceptible populations. This study reports rotavirus infection and disease in a community based birth cohort in Vellore.
METHODS: Bimonthly surveillance and diarrheal stool were collected from 452 children enrolled at birth, of whom 373 completed three years of follow up. Samples were screened for rotavirus by an ELISA and genotyped by reverse transcription polymerase chain reaction for VP7 and VP4 genes. Rotavirus incidence rates were calculated using Poisson regression equations. Risk factors associated with symptomatic and asymptomatic rotavirus infections were compared using multiple logistic regression.
RESULTS: A total of 1149 episodes of rotavirus infections occurred in 94.4% children in the cohort. Incidence of rotavirus infection was 1.04 (0.97-1.1) per child-year with 0.75 asymptomatic and 0.29 symptomatic infections per child-year. About 18% of the children were infected in the first month, mainly with the G10P[11] strain. Rotavirus infections were more prevalent during October-March, but seasonality was not as marked in rotavirus disease. Rotavirus was associated with 15.1% of mild diarrhea, 38.9% of moderate/severe diarrhea and 66.7% of very severe diarrhea. Four common G types - G1 (26.8%), G2 (16%), G10 (11.2%) and G9 (9.6%) were seen, with high rates of mixed infections and untypable samples. Male gender, presence of siblings and low maternal education were associated with rotavirus disease.
CONCLUSION: This study demonstrates that rotavirus is the most common cause of gastroenteritis in the community, and indicates that since rotavirus caused the greatest proportion of moderate and severe disease, targeted interventions such as vaccines are needed for rotavirus, in addition to health education, sanitation and appropriate treatment to decrease diarrheal disease in communities.
Copyright © 2014. Published by Elsevier Ltd.

Entities:  

Mesh:

Year:  2014        PMID: 25091680     DOI: 10.1016/j.vaccine.2014.03.039

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  11 in total

1.  Prevalence of rotavirus, norovirus and enterovirus in diarrheal diseases in Himachal Pradesh, India.

Authors:  Swapnil Jain; Nutan Thakur; Neelam Grover; Jitendraa Vashistt; Harish Changotra
Journal:  Virusdisease       Date:  2016-02-03

Review 2.  Options for improving effectiveness of rotavirus vaccines in developing countries.

Authors:  Marion S Tissera; Daniel Cowley; Nada Bogdanovic-Sakran; Melanie L Hutton; Dena Lyras; Carl D Kirkwood; Jim P Buttery
Journal:  Hum Vaccin Immunother       Date:  2016-11-11       Impact factor: 3.452

3.  18β-Glycyrrhetinic acid inhibits the apoptosis of cells infected with rotavirus SA11 via the Fas/FasL pathway.

Authors:  Xiaoyan Wang; Fang Xie; Xiaofeng Zhou; Ting Chen; Ye Xue; Wei Wang
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

4.  Seasonality and within-subject clustering of rotavirus infections in an eight-site birth cohort study.

Authors:  J M Colston; A M S Ahmed; S B Soofi; E Svensen; R Haque; J Shrestha; R Nshama; Z Bhutta; I F N Lima; A Samie; L Bodhidatta; A A M Lima; P Bessong; M Paredes Olortegui; A Turab; V R Mohan; L H Moulton; E N Naumova; G Kang; M N Kosek
Journal:  Epidemiol Infect       Date:  2018-03-14       Impact factor: 4.434

5.  Conditional random slope: A new approach for estimating individual child growth velocity in epidemiological research.

Authors:  Michael Leung; Diego G Bassani; Amy Racine-Poon; Anna Goldenberg; Syed Asad Ali; Gagandeep Kang; Prasanna S Premkumar; Daniel E Roth
Journal:  Am J Hum Biol       Date:  2017-04-21       Impact factor: 1.937

6.  Nonsecretor Histo-blood Group Antigen Phenotype Is Associated With Reduced Risk of Clinical Rotavirus Vaccine Failure in Malawian Infants.

Authors:  Louisa Pollock; Aisleen Bennett; Khuzwayo C Jere; Queen Dube; Jonathan Mandolo; Naor Bar-Zeev; Robert S Heyderman; Nigel A Cunliffe; Miren Iturriza-Gomara
Journal:  Clin Infect Dis       Date:  2019-09-27       Impact factor: 9.079

7.  Epidemiology of rotavirus diarrhea among children less than 5 years hospitalized with acute gastroenteritis prior to rotavirus vaccine introduction in India.

Authors:  C P Girish Kumar; Sidhartha Giri; Mamta Chawla-Sarkar; Varanasi Gopalkrishna; Shobha D Chitambar; Pratima Ray; S Venkatasubramanian; Biswajyoti Borkakoty; Subarna Roy; Jyothi Bhat; Bhagirathi Dwibedi; Vijayachari Paluru; Pradeep Das; Rashmi Arora; Gagandeep Kang; Sanjay M Mehendale
Journal:  Vaccine       Date:  2020-11-07       Impact factor: 3.641

8.  Impact of maternal antibodies and microbiota development on the immunogenicity of oral rotavirus vaccine in African, Indian, and European infants.

Authors:  Edward P K Parker; Christina Bronowski; Kulandaipalayam Natarajan C Sindhu; Sudhir Babji; Blossom Benny; Noelia Carmona-Vicente; Nedson Chasweka; End Chinyama; Nigel A Cunliffe; Queen Dube; Sidhartha Giri; Nicholas C Grassly; Annai Gunasekaran; Deborah Howarth; Sushil Immanuel; Khuzwayo C Jere; Beate Kampmann; Jenna Lowe; Jonathan Mandolo; Ira Praharaj; Bakthavatsalam Sandya Rani; Sophia Silas; Vivek Kumar Srinivasan; Mark Turner; Srinivasan Venugopal; Valsan Philip Verghese; Alistair C Darby; Gagandeep Kang; Miren Iturriza-Gómara
Journal:  Nat Commun       Date:  2021-12-15       Impact factor: 14.919

9.  In vitro Antiviral Activity of Rubia cordifolia Aerial Part Extract against Rotavirus.

Authors:  Yuanyuan Sun; Xuepeng Gong; Jia Y Tan; Lifeng Kang; Dongyan Li; Jihong Yang; Guang Du
Journal:  Front Pharmacol       Date:  2016-09-13       Impact factor: 5.810

10.  Enteric pathogens and associated risk factors among under-five children with and without diarrhea in Wegera District, Northwestern Ethiopia.

Authors:  Hailemariam Feleke; Girmay Medhin; Almaz Abebe; Birhan Beyene; Helmut Kloos; Daniel Asrat
Journal:  Pan Afr Med J       Date:  2018-01-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.